Literature DB >> 28687613

Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder.

Hsiao-Ying Kuo1, Fu-Chin Liu2.   

Abstract

The striatum comprises two neurochemical compartments: striosomes and the matrix. Striosomal and matrix compartments receive inputs from limbic system-related and sensorimotor cortices, respectively. Here, we investigate the impact on the corticostriosomal pathway in the valproic acid (VPA)-induced autism spectrum disorder mouse model. VPA administration during the neurogenesis time windows of striosomes, but not the matrix, resulted in aberrant compartmentation [i.e., maternal VPA injections at embryonic day (E)12.75 decreased μ-opioid receptor-positive striosomes, but increased calbindin-positive matrix in the rostral striatum]. VPAE12.75 treatment also impaired the aggregation of cells pulse labeled with 5-bromo-2'-deoxyuridine at E12.75 into striosomal cell clusters, which suggests defective segregation of striosomal cells from matrix cells. This possibility was supported by our findings that VPAE12.75 treatment altered the expression of ephrinA5 and EphA4, two molecules that are related to compartmental segregation. In the VPAE12.75 neocortex, Foxp2-positive neurons were decreased in layer VI, but increased in layer V, which projects to the striosomal compartment. We also investigated VPA effects on the corticostriosomal pathway. VPAE12.75 treatment decreased the putative corticostriosomal synapses of striosomal neurons and induced an aberrant pattern of isolation stress-induced ultrasonic vocalizations. Of interest, risperidone treatments conjointly improved ultrasonic vocalizations and restored the striosomal compartment in VPAE12.75 pups. Collectively, dysfunctional corticostriatal pathways, particularly via the aberrant striosomal compartment, may be involved in autism spectrum disorder pathophysiology.-Kuo, H.-Y., Liu, F.-C. Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder. © FASEB.

Entities:  

Keywords:  risperidone; striatum; striosome; ultrasonic vocalizations

Mesh:

Substances:

Year:  2017        PMID: 28687613     DOI: 10.1096/fj.201700054R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Combinatorial Developmental Controls on Striatonigral Circuits.

Authors:  Ayano Matsushima; Ann M Graybiel
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  Foxp1 regulation of neonatal vocalizations via cortical development.

Authors:  Noriyoshi Usui; Daniel J Araujo; Ashwinikumar Kulkarni; Marissa Co; Jacob Ellegood; Matthew Harper; Kazuya Toriumi; Jason P Lerch; Genevieve Konopka
Journal:  Genes Dev       Date:  2017-11-14       Impact factor: 11.361

Review 3.  Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Front Cell Neurosci       Date:  2018-11-20       Impact factor: 5.505

Review 4.  Synaptic Wiring of Corticostriatal Circuits in Basal Ganglia: Insights into the Pathogenesis of Neuropsychiatric Disorders.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  eNeuro       Date:  2019-06-05

Review 5.  Nuclear receptor corepressors in intellectual disability and autism.

Authors:  Yan Kong; Wenjun Zhou; Zheng Sun
Journal:  Mol Psychiatry       Date:  2020-02-07       Impact factor: 15.992

6.  Timing and Intertemporal Choice Behavior in the Valproic Acid Rat Model of Autism Spectrum Disorder.

Authors:  William E DeCoteau; Adam E Fox
Journal:  J Autism Dev Disord       Date:  2021-06-11

7.  Pathological alterations in striatal compartments in the human brain of autism spectrum disorder.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Mol Brain       Date:  2020-05-27       Impact factor: 4.041

8.  mTOR Suppresses Macroautophagy During Striatal Postnatal Development and Is Hyperactive in Mouse Models of Autism Spectrum Disorders.

Authors:  Ori J Lieberman; Veronica Cartocci; Irena Pigulevskiy; Maya Molinari; Josep Carbonell; Miguel Bellés Broseta; Michael R Post; David Sulzer; Anders Borgkvist; Emanuela Santini
Journal:  Front Cell Neurosci       Date:  2020-03-31       Impact factor: 5.505

9.  Unbiased identification of novel transcription factors in striatal compartmentation and striosome maturation.

Authors:  Maria-Daniela Cirnaru; Sicheng Song; Kizito-Tshitoko Tshilenge; Chuhyon Corwin; Justyna Mleczko; Carlos Galicia Aguirre; Houda Benlhabib; Jaroslav Bendl; Pasha Apontes; John Fullard; Jordi Creus-Muncunill; Azadeh Reyahi; Ali M Nik; Peter Carlsson; Panos Roussos; Sean D Mooney; Lisa M Ellerby; Michelle E Ehrlich
Journal:  Elife       Date:  2021-10-05       Impact factor: 8.140

10.  Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.

Authors:  Viktor Román; Nika Adham; Andrew G Foley; Lynsey Hanratty; Bence Farkas; Balázs Lendvai; Béla Kiss
Journal:  Psychopharmacology (Berl)       Date:  2021-07-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.